Background: Diabetes is a disease of increasing worldwide prevalence and is the main cause of chronic renal failure. Type 1 diabetic patients with chronic renal failure have the following therapy options: kidney transplant from a living donor, pancreas after kidney transplant, simultaneous pancreas-kidney transplant, or awaiting a deceased donor kidney transplant. for type 2 diabetic patients, only kidney transplant from deceased or living donors are recommended. Patient survival after kidney transplant has been improving for all age ranges in comparison to the dialysis therapy. the main causes of mortality after transplant are cardiovascular and cerebrovascular events, infections and neoplasias. Five-year patient survival for type 2 diabet...
Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients wi...
Cardiovascular outcomes after kidney–pancreas and kidney–alone transplantation.BackgroundThis study ...
Type 1 as well as Type 2 diabetic patients in end-stage renal failure and with no contraindications ...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3 million Americans. ...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3millionAmericans. It...
In diabetic patients cardiovascular morbidity and mortality is still a major problem. Our aim was to...
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved m...
In diabetic patients cardiovascular morbidity and mortality is still a major problem. Our aim was to...
Background/objectives: This thesis examines transplant modality and long-term outcomes in type 1 dia...
Introduction: The purpose of this study was to compare the short-term and long-term kidney transplan...
In the early era of transplantation, it was common practice to exclude diabetic patients since the o...
Post-transplant diabetes mellitus (PTDM) is a common problem after kidney transplantation (KT), occu...
Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients wi...
Cardiovascular outcomes after kidney–pancreas and kidney–alone transplantation.BackgroundThis study ...
Type 1 as well as Type 2 diabetic patients in end-stage renal failure and with no contraindications ...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3 million Americans. ...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3millionAmericans. It...
In diabetic patients cardiovascular morbidity and mortality is still a major problem. Our aim was to...
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved m...
In diabetic patients cardiovascular morbidity and mortality is still a major problem. Our aim was to...
Background/objectives: This thesis examines transplant modality and long-term outcomes in type 1 dia...
Introduction: The purpose of this study was to compare the short-term and long-term kidney transplan...
In the early era of transplantation, it was common practice to exclude diabetic patients since the o...
Post-transplant diabetes mellitus (PTDM) is a common problem after kidney transplantation (KT), occu...
Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients wi...
Cardiovascular outcomes after kidney–pancreas and kidney–alone transplantation.BackgroundThis study ...
Type 1 as well as Type 2 diabetic patients in end-stage renal failure and with no contraindications ...